Theo Health develops high-performance compression garments (starting with the Theo Alpha Shorts) that embed inertial measurement units to track reps, depth, tempo, balance, symmetry, and knee alignment in real time. Each garment pairs with a removable modular “brain” that delivers lab-grade insights and post-session reports to athletes and strength & conditioning coaches. The company emphasizes female physiology to address the gender data gap in injury studies and aims to reduce injuries and aid recovery. Theo emerged from stealth after focusing on IP protection, product development, and team building, and has secured £1.2M in funding. It has recruited elite athletes and coaches into an Alpha testing programme and signed on Xander Schauffele as an investor and founding ‘Alpha Athlete’. The firm plans Beta pilots with a top European football club and expects a mass-market launch by summer 2027. Leadership highlights include CEO and founder Jodie Sinclair and medical advisor Dr. Cordelia Carter.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Jul 2025